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Objective. Alanine Aminotransferase is an enzyme associated with not only liver diseases, liver conditions, and metabolic syndrome,
but also inflammation. Periodontitis is associated with increased cytokines and other markers of inflammation. The purpose of
this study is to determine if an independent association between Alanine Aminotransferase and periodontitis exists. Methods.
Data from the 2009-2010 and 2011-2012 National Health and Nutrition Surveys (NHANES) were combined. Data concerning
periodontitis and Alanine Aminotransferase were extracted and analyzed with Rao Scott Chi-square and logistic regressions. Serum
Alanine Aminotransferase was dichotomized at 40 units/liter, and periodontitis was dichotomized to the presence or absence of
periodontitis. Results. In bivariate Chi-square analyses, periodontitis and Alanine Aminotransferase were associated (𝑝 = 0.0360)
and remained significant in unadjusted logistic regression (OR = 1.30 [95% CI: 1.02, 1.65]). However, when other known risk factors
of periodontitis were included in the analyses, the relationship attenuated and failed to reach significance (adjusted OR = 1.17 [95%
CI: 0.85, 1.60]). Conclusion. Our study adds to the literature a positive but attenuated association of serum Alanine Aminotransferase
with periodontitis which failed to reach significance when other known, strong risk factors of periodontitis were included in the
analysis.

1. Introduction
Alanine Aminotransferase is an enzyme that is a catalyst
in the transfer of –NH2 group from L-alanine to alphaketoglutarate creating pyruvate and L-glutamate which are
important reactions in the tricarboxylic acid cycle (also
known as the Krebs cycle or the citric acid cycle of energy
production) [1]. Alanine Aminotransferase is primarily found
in hepatocyte intracellular fluid [1]. Serum levels are used
to detect hepatic distress and diseases such as chronic viral
infections, autoimmune hepatitis, and steatohepatitis, as well
as other conditions such as celiac disease, muscle injury,
hemochromatosis, and nonalcoholic fatty liver disease [1].
Serum levels also increase with extreme physical exertion,
excessive alcohol intake, some medications, and metabolic

syndrome [1], the clustering and synergistic effects of interrelated risk factors leading to diseases of chronic inflammation
(cardiovascular disease, stroke, and/or diabetes) [2–5]. Many
mechanisms and pathways may be involved in elevated
serum Alanine Aminotransferase levels; however, chronic
inflammation is one potential mechanism for its increase.
Periodontitis is the destruction of the soft and hard oral
tissue supporting the teeth as the result of a biofilm (bacteria, fungi, and viruses), genetic susceptibility, and plaqueinduced chronic inflammation, among other risk factors
[6–13]. Systemic chronic inflammation negatively impacts
periodontal health. Periodontitis is a public health concern
as it is a common disease affecting 46% of US adults (64.7
million individuals) [14]. Periodontitis affects oral health
quality of life, the number of remaining teeth in older adults,
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and glycemic control in individuals with diabetes and has
social and financial impacts.
The purpose of this study is to determine if there exists
an independent association of Alanine Aminotransferase and
periodontitis. The theoretical basis is that Alanine Aminotransferase levels are increased with inflammation and periodontitis is a disease of chronic inflammation. Researchers
using animal models indicated that such an association exists
[15–17]. Researchers also determined that an association of
periodontitis and Alanine Aminotransferase existed using a
convenience sample of 2225 young Japanese male university
students [18]. However, the number of participants with
periodontitis was small (4.7%) in that study. The rationale
for this study is that there is a need for a large, nationally
representative study to determine if an association exits
between periodontitis and Alanine Aminotransferase. Such
knowledge could help inform decisions by medical personnel
concerning dental referrals for patients with high Alanine
Aminotransferase levels.
The null hypothesis for this research is that the adjusted
odds ratio for the association of high levels of serum Alanine
Aminotransferase (≥40 units/liter) on periodontitis is the
same as the adjusted odds ratio for normal levels of serum
Alanine Aminotransferase (<40 units/liter) on periodontitis.

2. Materials and Methods
This study was acknowledged by the West Virginia University
Institutional Review Board (protocol 14010466515). The study
was conducted using the Strengthening the Reporting of
Observational studies in Epidemiology (STROBE) guidelines.
2.1. Data Source. Data used in this study were from the combined 2009-2010 and 2011-2012 National Health and Nutrition Examination Surveys (NHANES) which were collected
by researchers from the Centers for Disease Control and
Prevention (CDC). The NHANES surveys had a stratified,
multistage probability sampling strategy. Noninstitutionalized civilian individuals were selected for the survey. They
provided written informed consent. Each participant was
interviewed and had a physical evaluation in NHANES MEC
(Mobile Examination Center).
The periodontal examinations were completed by licensed dentists. He or she had an available halogen light, a
HuFriedy™ periodontal probe, and a mouth mirror for each
examination. The examination was limited to individuals
who were not edentulous and who did not have heart transplants, artificial valves, congenital heart disease, rheumatic
fever, hemophilia, kidney disease with dialysis, or a pacemaker.
Alanine Aminotransferase level in serum or plasma was
determined by NHANES researchers using a kinetic rate
method. Alanine Aminotransferase is a catalyst in the reversible reaction of L-alanine and a-ketoglutarate to pyruvate
and L-glutamate. In the analysis, the pyruvate is further
reduced. The rate of change in absorbance at 340 nm over
time is proportional to the Alanine Aminotransferase level
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[19]. The details of the NHANES procedures are available at
http://www.cdc.gov/nchs/nhanes.htm.
2.2. Eligible Study Population. The researchers for this study
used a subset of the available data from the NHANES 2009–
2012 surveys. Eligible participants were aged 30–69 years
and had complete data on periodontitis and serum Alanine
Aminotransferase. The eligible sample included 5,758 participants.
2.3. Dependent Variable. The periodontal variable was the
dependent variable for this study. Periodontitis was dichotomized as a yes/no variable to establish an adequate sample
size. Even though several years of NHANES data were
combined, there were too few participants in the categories
of “mild periodontitis” and “severe periodontitis” who also
had Alanine Aminotransferase data to use those categories
as separate categories. Instead, the categories were no periodontitis (the reference group) and periodontitis (mild,
moderate, or severe) using the definition of periodontitis
for population-based surveillance supported by the CDC in
partnership with the American Academy of Periodontology
[20]. Their more detailed definition of periodontitis includes
“mild periodontitis” in which there are at least 2 interproximal
areas in which the attachment loss is at least 3 mm and there
are at least 2 interproximal areas on different teeth in which
the probing depth is at least 4 mm or at least one area with
a probing depth of 5 mm; “moderate periodontitis” in which
there are at least 2 interproximal areas on different teeth in
which the attachment loss is at least 4 mm or there are at least
2 interproximal areas on different teeth in which the probing
depth is at least 5 mm; and “severe periodontitis” in which
there are at least 2 interproximal areas which are on different
teeth in which the attachment loss is at least 6 mm and there
is at least 1 interproximal area in which the probing depth is
at least 5 mm [20].
2.4. Independent Variable and Other Variables. The keyindependent variable was serum Alanine Aminotransferase.
It was dichotomized at <40 units/liter (the reference group)
and ≥40 units/liter. The cut-point at ≥40 units/liter is
routinely used and has been previously reported in peerreviewed literature to determine normal and high levels of
Alanine Aminotransferase in adults [21–23].
The other variables that were included in this study to
account for confounding or to further explain the variance
for periodontitis included sociodemographic and behavioral variables: sex, race/ethnicity, education, age, income to
poverty ratio, smoking, body mass index, insurance coverage,
presence of diabetes mellitus, and alcohol consumption.
The categories for the additional variables were sex (male
versus female), race/ethnicity, (non-Hispanic black, Mexican
American, and other versus non-Hispanic white), education (high school, less than high school, and some college
versus college degree and above), age (45–54, 55 years and
above versus 30–44 years), family income to poverty ratio
(less than 2 versus 2 and above), smoking status (current,
former smoker versus never smoker), alcohol consumption
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(moderate, heavy versus no consumption), body mass index
(25–29, 30 and above versus 0–24), insurance coverage (no
versus yes), and diabetes (yes versus no).
2.5. Statistical Analyses. Due to the complex study design,
the analysis accounted for clustering, stratification, selected
sample population, and sample weights. Descriptions of
the sample population, bivariate (Rao Scott Chi-square)
analyses with periodontitis, and logistic regression analyses
were completed. In logistic regression model development,
significant variables from the bivariate analyses (at 𝑝 < 0.05)
were included in the model. The statistics package that was
used was SAS 9.3® (Cary, NC).

3. Results
Table 1 has the results of the sample description. There
were 5758 eligible participants, 50.1% of whom were female.
Considering race/ethnicity, 68.1% of participants were nonHispanic white, 10.6% of participants were non-Hispanic
black, and 8.4% of participants were Mexican American.
There were 41.9% of participants who were aged 30–44 years;
28.7% of participants who were 45–54 years; and 29.4% of
participants who were 55–69 years. There were 64.2% of participants who attended some college courses, technical school
courses, or above. Most had an income to poverty ratio above
2.0 (69.9%). There were 56.1% of participants who were never
smokers and 20.5% of participants who never used alcohol.
There were 27.0% of participants who had a body mass index
of 0–24, 36.0% of participants who had a body mass index
of 25–29, and 37.0% of participants who had a body mass
index of 30 and above. There were 12.1% of participants who
had ≥40 units/liter Alanine Aminotransferase and 39.9% of
participants who had periodontitis.
The Chi-square bivariate analyses and standard errors
are presented in Table 2. There was a significant relationship
(𝑝 = 0.0360) of serum Alanine Aminotransferase levels
≥40 U/L and periodontitis. Other significant relationships
(at 𝑝 < 0.0001) were with periodontitis and sex; race/
ethnicity; age; education; family income to poverty ratio;
alcohol consumption; smoking status; insurance coverage;
and diabetes mellitus. Body mass index was also significant at
𝑝 = 0.0151.
Table 3 has the results of the logistic regression of serum
Alanine Aminotransferase on periodontitis. The odds ratio,
in unadjusted logistic regression, for periodontitis associated
with higher levels of serum Alanine Aminotransferase was
1.30 (95% confidence interval: 1.02, 1.65).
An Adjusted Model was created which included sex
(male versus female), race/ethnicity, (non-Hispanic black,
Mexican American, and other versus non-Hispanic white),
education (high school, less than high school, and some
college versus college degree and above), age (45–54, 55 years
and above versus 30–44 years), family income to poverty ratio
(less than 2 versus 2 and above), smoking status (current,
former smoker versus never smoker), alcohol consumption
(moderate, heavy versus no consumption), body mass index
(25–29, 30 and above versus 0–24), insurance coverage (no
versus yes), and diabetes (yes versus no). The adjusted odds
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Table 1: Sample characteristics, NHANES 2009–2012, 𝑛 = 5758.

Alanine Aminotransferase (serum)
<40 units/liter (normal)
≥40 units/liter
Periodontitis
No
Yes
Mild
Moderate
Severe
Sex
Male
Female
Race/ethnicity
Non-Hispanic white
Non-Hispanic black
Mexican American
Other
Age
30–44 years
45–54 years
55–69 years
Education
Less than HS
HS graduate
Some coll./tech.
Coll./tech. graduate
Family income to poverty ratio
0 to less than 2.00
2.00 and above
Alcohol consumption
Nonuse
Moderate use
Heavy use
Smoking status
Current
Former
Never
Body mass index
0–24
25–29
30 and above
Insurance
Yes
No
Diabetes
Yes
No

Number

Weighted
percentage

5,062
696

87.9
12.1

2,946
2,812
207
2,048
557

60.1
39.9
3.0
30.1
6.9

2,884
2,874

49.9
50.1

2,308
1,231
932
1,287

68.1
10.6
8.4
13.0

2,407
1,536
1,815

41.9
28.7
29.4

1,393
1,218
1,613
1,527

15.5
20.4
29.6
34.6

2,417
2,853

30.1
69.9

1,293
2,041
1,391

20.5
51.1
28.4

1,219
1,307
3,229

19.0
24.9
56.1

1,478
1,995
2,252

27.0
36.0
37.0

4,178
1,580

79.3
20.7

732
2,394

18.0
82.0

SE: standard error of row percent; HS: high school; and coll./tech.: college
technical school.

ratio for periodontitis associated with higher levels of serum
Alanine Aminotransferase was 1.17 (95% confidence interval:
0.85, 1.60).
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Table 2: Periodontitis status in Rao Scott Chi-square analysis, NHANES, 2009–2012.

Alanine Aminotransferase (serum)
<40 units/liter (normal)
≥40 units/liter
Sex
Male
Female
Race/ethnicity
Non-Hispanic white
Non-Hispanic black
Mexican American
Other
Age
30–44 years
45–54 years
55–69 years
Education
Less than HS
HS graduate
Some coll./tech.
Coll./tech. graduate
Family income to poverty ratio
0 to less than 2.00
2.00 and above
Alcohol consumption
Nonuse
Moderate use
Heavy use
Smoking status
Current
Former
Never
Body mass index
0–24
25–29
30 and above
Insurance
Yes
No
Diabetes
Yes
No

Frequency negative

Weighted row%

Frequency positive

Weighted row%

SE

2623
323

60.8
54.5

2439
373

39.2
38.2

1.5
3.1

1185
1761

50.9
69.2

1699
1113

49.1
30.8

1.5
1.7

1445
502
350
649

65.9
45.5
41.4
53.1

863
729
582
638

34.1
54.5
58.6
46.9

1.9
2.5
1.8
2.1

1602
715
629

70.0
55.7
45.8

805
821
1186

27.0
44.3
54.2

1.5
2.2
2.1

446
529
884
1084

35.7
51.1
59.6
76.9

947
689
729
443

64.6
48.9
40.4
23.1

1.6
2.4
1.9
1.5

986
1753

45.8
67.1

1431
1100

54.1
32.9

1.6
1.6

643
1257
587

57.9
68.8
50.2

659
784
804

42.1
31.2
40.8

2.4
1.8
2.3

400
620
1926

35.3
58.3
69.3

819
687
1303

64.7
41.7
30.7

1.9
2.5
1.3

805
1014
1109

63.2
60.2
57.7

673
981
1143

36.8
39.8
42.3

1.8
1.6
2.0

2346
600

64.6
42.7

1832
980

35.4
57.3

1.5
2.0

244
1299

48.0
50.7

488
1095

59.2
38.2

3.2
1.9

𝑝 value
0.0360

<0.0001

<0.0001

<0.0001

<0.0001

<0.0001

<0.0001

<0.0001

0.0151

<0.0001

<0.0001

SE: standard error of row percent; HS: high school; and coll./tech.: college or technical school.

4. Discussion
In this study we evaluated the relationship of Alanine Aminotransferase on periodontitis in a large, nationally representative sample of 5758 participants. The results of this study
included an initial significant association of Alanine Aminotransferase with periodontitis (odds ratio 1.30, 95% CI, 1.02,
1.65), which remained positive but attenuated and failed

to reach significance with the addition of other variables
(adjusted odds ratio 1.17, 95% CI, 0.85, 1.60). Serum Alanine
Aminotransferase was dichotomized at <40 units/liter (the
reference group) and ≥40 units/liter in this study, although
other researchers have used lower cut-points, such as ≥30
units/liter [24], and some researchers have used a higher
level such as ≥41 units/liter [18]. When a cut-point of ≥30
units/liter was used with these data, the adjusted odds ratio
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Table 3: Logistic regression of serum Alanine Aminotransferase on
periodontal status: NHANES, 2009–2012.

Periodontitis
Yes
No
Sex
Male
Female
Race/ethnicity
Non-Hispanic white
Non-Hispanic black
Mexican American
Other
Education
Less than high school
High school
Some college
College degree or above
Family income to poverty
ratio
Less than 2.00
2.00 and above
Insurance coverage
No
Yes
Body mass index
0 to less than 25
25 to less than 30
30 and above
Smoking
Yes
No
Alcohol consumption
Heavy
Moderate
None
Diabetes
Yes
No

Unadjusted OR
(95% CI)

Adjusted OR
(95% CI)

1.30 (1.02, 1.65)
1.00 (reference)

1.17 (0.85, 1.60)
1.00 (reference)
2.55 (2.07, 3.15)
1.00 (reference)
1.00 (reference)
2.07 (1.50, 2.86)
2.21 (1.52, 3.23)
1.63 (1.13, 2.37)
2.62 (1.67, 4.12)
1.71 (1.20, 2.44)
1.31 (0.94, 1.82)
1.00 (reference)

1.36 (1.06, 1.73)
1.00 (reference)
1.74 (1.14, 2.68)
1.00 (reference)
1.00 (reference)
0.98 (0.66, 1.46)
0.92 (0.63, 1.32)
3.26 (2.28, 4.68)
1.00 (reference)
0.92 (0.63, 1.34)
0.66 (0.47, 0.93)
1.00 (reference)
1.32 (0.93, 1.87)
1.00 (reference)

OR: odds ratio; AOR: adjusted odds ratio; CI: confidence interval.

was 1.16 (95% CI, 0.90, 1.50) and when a cut-point of ≥41
units/liter was used with these data, the adjusted odds ratio
was 1.26 (0.89, 1.77).
The results of this study are similar to the results of
researchers studying salivary Alanine Aminotransferase in
a sample of 50 participants in Romania. They determined
that salivary Alanine Aminotransferase was not statistically

different among individuals who had periodontitis as compared with individuals who did not have periodontitis [25].
The study in Romania differed from this current study in the
source of Alanine Aminotransferase (saliva rather than blood
or serum) and study population size.
It has been suggested that changes in enzymatic activity
indicate metabolic change in inflammation and that Alanine
Aminotransferase release increases with cell injury and death.
Researchers in a study of 49 older adult Japanese patients
with chronic periodontitis found Alanine Aminotransferase
to be associated with periodontal inflammation [26]. Several
of the same researchers conducted an 18-month longitudinal study of 85 patients with chronic periodontitis in
four Japanese university hospitals and found that salivary
Alanine Aminotransferase in combination with the ratio of
Porphyromonas gingivalis to total bacteria had a sensitivity
of 0.4 and a specificity of 0.96 for the prediction of the
progression of periodontitis [27]. Salivary Alanine Aminotransferase was increased in individuals with periodontitis
disease, as compared with controls in a study of 40 patients
in India [28]. Researchers found a correlation of salivary
Alanine Aminotransferase and periodontitis in a sample of
60 participants [28]. These existing studies differed from the
current study in that they were small and the researchers used
salivary Alanine Aminotransferase for analyses.
In a study conducted in Japan with serum Alanine
Aminotransferase, a positive association of elevated serum
Alanine Aminotransferase and pocket depth was present
only in males with low alcohol consumption and at least 3
components of the metabolic syndrome (waists at or above
90 cm in males and 80 cm in females; triglycerides at or
above 150 mg/dL or treatment for triglycerides; high density
lipoprotein below 40 mg/dL in males or below 50 mg/dL
for females; systolic blood press at or above 130 mmHg or
diastolic blood pressure at or above 85 or medication for high
blood pressure; and fasting glucose at or above 100 mg/dL or
treatment for elevated glucose) [29].
Researchers who conducted a systematic review with
the association of Alanine Aminotransferase on mortality
indicated that Alanine Aminotransferase had a complex and
inconsistent relationship, which was more predictive in older
adults with extremely low levels of Alanine Aminotransferase
[30]. The method of collection of the Alanine Aminotransferase was not discussed in the review of the 12 articles
selected for the meta-analysis [30].
4.1. Strengths, Limitations, and Sources of Bias. Research
concerning Alanine Aminotransferase and periodontitis is
lacking. Alanine Aminotransferase collection methods differ
among researchers and researchers have used different cutpoints for Alanine Aminotransferase as well as different
definitions for periodontitis.
Our study strengths are its large, nationally representative sample; the use of definitions for population-based
surveillance of the CDC in partnership with the American Academy of Periodontology; standardized blood testing
procedures for Alanine Aminotransferase; and standardized/calibrated examiners. Since this study is large, many
variables were included in the multivariable analysis which
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are also independently related to periodontitis or may confound the relationship of Alanine Aminotransferase and
periodontitis, an option that is not available for small studies.
Our study limitations are the biases associated with selfreporting of education, income, insurance status, alcohol
consumption, and the reporting of diabetes mellitus. It is
possible that self-reports may be influenced by participants’
desires for providing a socially desirable response. However,
it would be expected that social desirability bias would likely
result in reports which would tend to direct the outcome to
supporting the null hypothesis that the odds ratio for the
association of high Alanine Aminotransferase and periodontitis is the same as the odds ratio for normal levels of Alanine
Aminotransferase and periodontitis. Another limitation was
not having enough participants to further refine periodontitis
as “mild,” “moderate,” and “severe.”
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[4]

[5]

[6]

[7]

[8]

5. Conclusion
Our study adds to the literature a positive but attenuated
association of periodontitis and Alanine Aminotransferase
which failed to reach significance when other known, strong
factors of periodontitis were included in the analysis.
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